A118G polymorphism of OPRM1 gene is associated with schizophrenia
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Genetic Predisposition to Disease MeSH
- Humans MeSH
- Polymorphism, Genetic * MeSH
- Receptors, Opioid, mu genetics MeSH
- Schizophrenia genetics physiopathology MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- OPRM1 protein, human MeSH Browser
- Receptors, Opioid, mu MeSH
Schizophrenia is ranked among multifactor diseases in whose pathogenesis, besides environmental factors, an interplay of functional polymorphisms of a larger number of candidate genes is involved. Neurodevelopmental abnormities are among the most accepted hypotheses in the etiology of schizophrenia. Recently, the role of oligodendrocytes in the development of the cortex has been cited repeatedly. During their various phases of differentiation oligodendrocytes present on their surfaces diverse receptors, among others the mu-opioid receptor (OPRM1). The study was focused on the relationship between the functional A118G polymorphism of the OPRM1 gene (rs1799971) and schizophrenia in groups of 130 male patients and 452 male controls. An association study revealed yet unpublished statistically significant difference of allelic and genotypic frequencies between the control and patient groups. According to our present knowledge, we assume that the OPRM1 gene polymorphism can influence the myelination of CNS neurons through regulations of expression of OPRM1 receptors on surfaces of oligodendrocytes. The neuronal myelination seems to be one of the important factors in the pathogenesis of schizophrenia.
See more in PubMed
Schizophr Res. 2007 Aug;94(1-3):273-80 PubMed
J Biol Chem. 2005 Sep 23;280(38):32618-24 PubMed
Neuroscience. 2007 Apr 14;145(4):1426-38 PubMed
J Am Acad Child Adolesc Psychiatry. 2005 Sep;44(9):934-41 PubMed
Schizophr Res. 2003 Dec 1;65(1):61-3 PubMed
Nature. 2006 Feb 23;439(7079):988-92 PubMed
Nature. 2005 Dec 22;438(7071):1162-6 PubMed
Glia. 2008 Jul;56(9):1017-27 PubMed
Neuroreport. 2006 Jan 23;17(1):23-6 PubMed
Am J Addict. 2004 Mar-Apr;13(2):139-50 PubMed
J Neurochem. 2007 Oct;103(1):77-87 PubMed
Biol Psychiatry. 2003 Jun 15;53(12):1075-85 PubMed
Harv Rev Psychiatry. 2009;17(3):214-25 PubMed
Biochim Biophys Acta. 2009 Sep;1790(9):869-77 PubMed
Schizophr Res. 2001 Oct 1;52(1-2):137-8 PubMed
Glia. 2005 Dec;52(4):336-43 PubMed
Neuroscience. 1999;88(4):1093-135 PubMed
Gene-Environment Interactions in Major Mental Disorders in the Czech Republic